Breaking: J&J ERISA Employee Benefit Lawsuit. Am I at Risk?

This Changes Everything for Benefits Leaders with Fiduciary Duty

A Johnson & Johnson employee filed a class action lawsuit on February 5, 2024, sending shockwaves through the benefits community. Alleging breach of fiduciary duty by the company, the lawsuit exposes alarming markups in prescription drug costs within the company’s health plan. Some of these markups are as high as 801% markup for an HIV drug, a 6,392% markup for a prostate cancer drug, a 9,592% markup for a leukemia drug, and a 12,403% markup for an MS drug. Despite hiring top benefit consultants and PBMs, serious mismanagement occurred, raising serious concerns about benefit management practices.

Together with Vivio, Frier Levitt co-founding partner Jonathan Levitt and CEO of Vivio Pramod John present a webinar, “Breaking: J&J ERISA Employee Benefit Lawsuit. Am I at Risk?”. During this webinar, the panelists delve into the class action, answering the following question:

(1) Is this lawsuit a big deal?
(2) Am I at personal risk?
(3) Could my company be sued?
(4) What should I do?

Who is this webinar for? Self-funded employers, benefits consultants and employee benefits professionals.

To learn more, visit: www.frierlevitt.com

Видео Breaking: J&J ERISA Employee Benefit Lawsuit. Am I at Risk? канала Frier Levitt